glp-1 treatment for newly diagnosed diabetes guidelines Medications Infographic New diabetes medicines funded: empagliflozin

To improve bile secretion, consider bile stimulating supplements such as artichoke extract and dandelion

The injectable ERR agonist Slu-pp-332 is studied in parallel for its influence on mitochondrial biogenesis and oxidative metabolism, together exploring complementary effects on energy expenditure and body composition in research models

Clinically, this potent effect is demonstrated by agents like semaglutide, which, in phase 2 trials, achieved MASH resolution without worsening fibrosis in a significant percentage of patients (Newsome et al., 2021

Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles